Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

Overview of attention for article published in Journal of Neurology, August 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

policy: 1 policy source

Readers on

mendeley: 312 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 3 policy documents that reference this research output.

foslevodopa foscarbidopa - Clinical and Pharmacoeconomic combined Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 18 Oct 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

apomorphine hydrochloride - Clinical Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 29 May 2020

Levodopa / carbidopa (Drug Plan Submission) - Clinical Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 11 Jan 2018

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.